3Verbeke C, Leitch D, Menon K, et al. Redefining the R1 resec- tion in pancreatic cancer [J]. Br J Surg, 2006, 93(9): 1232- 1237.
4Chang D, Johns A, Merrett N, et al. argin clearance and out- come in resected pancreatic cancer[J]. J Clin Oncol, 2009, 27 (12): 2855-2862.
5Varadhachary G, Tamm E, Abbruzzese J, et al. Borderline re- sectable pancreatic cancer: Definitions, management, and role of preoperative therapy [J]. Ann Surg Oncol, 2006, 13(8): 1035- 1046.
6Jean RD, Philippe B, Nicolas R, et al. Pancreaticoduodeneetomy for pancreatic duetal adenocarcinoma: A French multicentre pro- spective evaluation of resection margins in 150 evaluable speci- mens[J]. HPB,2014,16(1): 20-33.
7Bilimoria K, Talamonti M, Sener S, et al. Effect of hospital vol- ume on margin status after pancreaticoduodenectomy for cancer [J]. J Am Coll Surg, 2008,207(7): 510-519.
8Lu DS, Rber HA, Krasny RM, et at. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT [J]. Am J Roem- genol, 1997,168(7): 1439-1443.
9Vargas R, Nino-Murcia M, Trueblood W, et at. MDCT in pan- creatic ade prediction of vascular invasion and re- sectability using a multiphasic technique with curved planar ref- ormations [ J ]. Am J Roentgenol, 2004, 182(5): 419 - 425.
10Hirota M, Shimada S, Yamamoto K, et al. Pancreatectomy using the no-touch isolation technique followed by extensive intraop- erative peritoneal lavage to prevent cancer cell dissemination : A pilot study[J]. JOP,2005,6(2): 143-151.
